Compare Kenvue Inc. Common Stock (KVUE) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Kenvue Inc. Common Stock trades at $17.64 (market cap $34.06B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Kenvue Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| KVUE | RPRX | |
|---|---|---|
Market Cap | $34.06B | $25.27B |
Volume | 23,267,228 | 3,671,183 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $63.96 |
52-Week Low | $14.11 | $35.44 |
Enterprise Value | $41.56B | $32.50B |
Dividend Yield | 4.74% | 1.66% |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
